Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.22.4
Stock-Based Compensation - Liberty - Outstanding Awards (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Additional disclosures      
Total unrecognized compensation cost related to unvested equity awards $ 31    
Weighted average period of recognition related to unvested equity awards (in years) 1 year 4 months 24 days    
Options, exercises in period, total intrinsic value $ 84 $ 144 $ 8
Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, vested in period, fair value $ 16 $ 13 $ 45
Liberty SiriusXM Group      
Additional disclosures      
Common stock reserved for issuance 6,900    
Liberty SiriusXM Group | Common Class A and B      
Number of options      
Outstanding at end of period 0    
Liberty SiriusXM Group | Series C      
Number of options      
Outstanding at beginning of period 7,369    
Granted 254    
Exercised (760)    
Forfeited/Cancelled (1)    
Outstanding at end of period 6,862 7,369  
Exercisable at end of period 4,883    
WAEP      
Outstanding at beginning of period $ 38.79    
Granted 44.29    
Exercised 31.22    
Forfeited/Cancelled 31.87    
Outstanding at end of period 39.83 $ 38.79  
Exercisable at end of period $ 37.89    
Additional disclosures      
Weighted average remaining life, outstanding 2 years 9 months 18 days    
Weighted average remaining life, exercisable 2 years 2 months 12 days    
Aggregate intrinsic value, outstanding $ 14    
Aggregate intrinsic value, exercisable $ 14    
Liberty SiriusXM Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 73    
Restricted stock weighted average grant-date fair value $ 41.28    
Formula One Group      
Additional disclosures      
Common stock reserved for issuance 7,100    
Formula One Group | Common Class A and B      
Number of options      
Outstanding at end of period 0    
Formula One Group | Series C      
Number of options      
Outstanding at beginning of period 9,114    
Granted 301    
Exercised (2,329)    
Outstanding at end of period 7,086 9,114  
Exercisable at end of period 5,625    
WAEP      
Outstanding at beginning of period $ 34.38    
Granted 57.92    
Exercised 31.96    
Outstanding at end of period 36.18 $ 34.38  
Exercisable at end of period $ 34.19    
Additional disclosures      
Weighted average remaining life, outstanding 3 years 9 months 18 days    
Weighted average remaining life, exercisable 3 years 6 months    
Aggregate intrinsic value, outstanding $ 167    
Aggregate intrinsic value, exercisable $ 144    
Formula One Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 74    
Restricted stock weighted average grant-date fair value $ 55.34    
Braves Group      
Additional disclosures      
Common stock reserved for issuance 3,100    
Braves Group | Common Class A and B      
Number of options      
Outstanding at end of period 0    
Braves Group | Series C      
Number of options      
Outstanding at beginning of period 3,125    
Granted 105    
Exercised (122)    
Outstanding at end of period 3,108 3,125  
Exercisable at end of period 1,493    
WAEP      
Outstanding at beginning of period $ 25.86    
Granted 26.20    
Exercised 18.12    
Outstanding at end of period 26.17 $ 25.86  
Exercisable at end of period $ 24.92    
Additional disclosures      
Weighted average remaining life, outstanding 4 years 4 months 24 days    
Weighted average remaining life, exercisable 3 years 10 months 24 days    
Aggregate intrinsic value, outstanding $ 19    
Aggregate intrinsic value, exercisable $ 11    
Braves Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 178    
Restricted stock weighted average grant-date fair value $ 31.55